Wacker adds cleanroom at Burghausen plant

Published: 6-Jul-2011
Design & Build Ingredients Hi Tech Manufacturing

To meet the purity standards of the medical, LED and electronics industries

Wacker, a German chemical group, has this month started up several silicone polymer production lines at its Burghausen site, expanding production of high-purity specialist silicones, encapsulation and coating compounds, as well as UV-activated silicones for the medical, LED and electronics industries.

Wacker has added a new cleanroom facility at the site to meet the purity standards of pharmaceuticals, semiconductors, LEDs and other applications.

The new facility meets Wacker’s Clean Operations principles said Dr Bernd Pachaly, head of the Engineering Silicones business unit. These include housing production, filling and logistics separately, accessed only through special airlocks.

Strict regulations also apply to the filling operations with special stipulations regarding clothing and hygiene, air and particle filters. The facility meets the ISO standard for Class 8 cleanrooms. Production steps are constantly monitored and documented.

The new clean operations facility produces Silpuran and Elastosil silicone elastomers for medical applications, as well as highly specialised Lumisil, Semicosil, and Wacker SilGel silicone products for encapsulating and coating electronic components. There is also a production line for UV silicones.

See more

You may also like

Design & Build

Exyte breaks ground on mRNA competence centre for WACKER

Read more
The global engineering expert has been named as EPCQ contract partner for the modular biopharmaceuticals build

Trending Articles

  1. Cellipont Bioservices completes ballroom-style cleanroom for cell therapy production The Texas-based contract development and manufacturing organisation (CDMO) has completed a new cleanroom for allogeneic cell therapy production
  2. BAM wins build of pilot plant for photonic chips The construction expert has announced it will build a pilot plant for the production of photonic chips at the High Tech Campus Eindhoven, a milestone in Europe’s push for chip sovereignty
  3. FDA recalls ByHeart Infant Formula amid infant botulism outbreak The US Food and Drug Administration (FDA) has begun investigations into manufacturing controls and cleanroom practices after infant botulism outbreak

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Design & Build

Exyte breaks ground on mRNA competence centre for WACKER

The global engineering expert has been named as EPCQ contract partner for the modular biopharmaceuticals build
Design & Build

Airkey expands manufacturing capabilities with new factory and faster delivery

After a strategic relocation and one-month intensive setup period, the company has resumed operations with enhanced capabilities, immediately demonstrating its upgraded capacity by completing a state-of-the-art ISO 5 cleanroom for an American food supplement manufacturer within just 15 days of restarting production
Design & Build

Novartis cuts 550 jobs at Stein site in Switzerland reshuffle

The pharmaceutical company has cut 550 jobs at its Stein site, while investing $80m in Schweizerhalle, after US tariffs are reduced on Swiss goods
Hi Tech Manufacturing

Getinge and SteriPro partner to expand off-site sterile processing across the US

Getinge has partnered with SteriPro to boost capacity for hospitals facing rising demand for high-quality sterile instruments
Design & Build

Cleanroom expert ClearSphere secures €6m to drive UK and Ireland expansion

The cleanroom and containment specialist has secured funding from BGF to accelerate growth, expand capabilities and scale operations
Hi Tech Manufacturing

FDA recalls ByHeart Infant Formula amid infant botulism outbreak

The US Food and Drug Administration (FDA) has begun investigations into manufacturing controls and cleanroom practices after infant botulism outbreak
Design & Build

Cellipont Bioservices completes ballroom-style cleanroom for cell therapy production

The Texas-based contract development and manufacturing organisation (CDMO) has completed a new cleanroom for allogeneic cell therapy production
Subscribe now